General Biotechnology

General Biotechnology

Patent First, Launch Faster: How Pharma Companies Align IP Filing with Commercialization to Win Market Share

Pharmas next competitive edge isnt just scienceits timing.
In a market where the first generic or biosimilar launch can determine years of revenue, good enough IP strategy is no longer enough. The real advantage is speed: aligning patent filings with c…

Patent First, Launch Faster: How Pharma Companies Align IP Filing with Commercialization to Win Market Share Read Post »

Biotechblog
Scroll to Top